Abstract: This application discloses oral liquid formulations of lipid/cholesterol-lowering drugs and blood pressure-lowering drugs, and combinations thereof, comprising surfactant(s) as stabilizer(s), which forms micelles with the drug molecules to enhance their solubility and stability.

Abstract: The present invention relates to injectable microspheres and formulations comprising the microspheres for controlled release of progestogen hormones.

Abstract: Drug-loaded microspheres containing both a steroidal anti-inflammatory drug and a non-steroidal anti-inflammatory drug and injectable formulations containing the microspheres for sustained release of both drugs are disclosed. Methods of making such drug-loaded microspheres, formulations, and use of them for treating pains and inflammations, especially those caused by rheumatoid arthritis or osteoarthritis using such microspheres and formulations are also described.

Abstract: Disclosed herein are pharmaceutical formulations of aprepitant suitable for parenteral administration including intravenous administration. The pharmaceutical formulations are stable and ready-to-use liposomes for the treatment of emesis and are particularly useful for treatment of chemotherapy or surgery-induced nausea and vomiting. Methods of preparation of the aprepitant formulations are also provided.

Abstract: Disclosed herein are pharmaceutical formulations of aprepitant suitable for parenteral administration including intravenous administration. The pharmaceutical formulations are stable and ready-to-use liposomes for the treatment of emesis and are particularly useful for treatment of chemotherapy or surgery-induced nausea and vomiting. Methods of preparation of the aprepitant formulations are also provided.

Abstract: The invention is directed to new nanoimprint resist and thin-film compositions for use in nanoimprinting lithography. The compositions permit economical high-throughput mass production, using nanoimprint processes, of patterns having sub-200 nm, and even sub-50 nm features.

Abstract: The invention is directed to new nanoimprint resist and thin-film compositions for use in nanoimprinting lithography. The compositions permit economical high-throughput mass production, using nanoimprint processes, of patterns having sub-200 nm, and even sub-50 nm features.

Abstract: A catalyst system is disclosed for use with elastomeric compositions, such as thermoset elastomers or thermoplastic elastomers. The catalyst system comprises at least one phenolic resin and at least one other ingredient selected from the group consisting of a non-transition metal halide and a nanoclay, provided that when the ingredient is nanoclay, the phenolic resin is brominated. Optionally, the catalyst system can include at least one acid or at least one hydrogen halide scavenger, or both. The catalyst system avoids the use of tin-containing materials, reducing environmental concerns. Elastomers and their preparation in the presence of the catalyst system are also disclosed, including the preparation of white elastomers.